Viking Wins First Round In Legal Battle With Ascletis Over THRβ Agonist

Both Firms Pursuing MASH Candidates

 
• By Dexter Jie Yan
  
trade secrets
Viking lodged ITC action against Ascletis in 2022, alleging unlawful and unfair methods of competition • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas